Literature DB >> 20130004

Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability.

Y Eugene Yu1, Lei Wen, Jeane Silva, Zhongyou Li, Karen Head, Khalid Sossey-Alaoui, Annie Pao, Lin Mei, John K Cowell.   

Abstract

LGI1 in humans is responsible for a predisposition to autosomal dominant partial epilepsy with auditory features (ADPEAF). However, mechanisms of how LGI1 mutations cause epilepsy remain unclear. We have used a mouse chromosome engineering strategy to create a null mutation for the gene ortholog encoding LGI1. The Lgi1 null mutant mice show no gross overall developmental abnormalities from routine histopathological analysis. After 12-18 days of age, the homozygous mutant mice all exhibit myoclonic seizures accompanied by rapid jumping and running and die shortly thereafter. The heterozygous mutant mice do not develop seizures. Electrophysiological analysis demonstrates an enhanced excitatory synaptic transmission by increasing the release of the excitatory neurotransmitter glutamate, suggesting a basis for the seizure phenotype. This mouse model, therefore, provides novel insights into the mechanism behind ADPEAF and offers a new opportunity to study the mechanism behind the role of LGI1 in susceptibility to myoclonic seizures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130004      PMCID: PMC2850618          DOI: 10.1093/hmg/ddq047

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Gene targeting in embryonic stem cells.

Authors:  R Ramírez-Solis; A C Davis; A Bradley
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

2.  Localization of a gene for partial epilepsy to chromosome 10q.

Authors:  R Ottman; N Risch; W A Hauser; T A Pedley; J H Lee; C Barker-Cummings; A Lustenberger; K J Nagle; K S Lee; M L Scheuer
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

3.  LGI1 mutations in autosomal dominant partial epilepsy with auditory features.

Authors:  R Ottman; M R Winawer; S Kalachikov; C Barker-Cummings; T C Gilliam; T A Pedley; W A Hauser
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

4.  Reexpression of LGI1 in glioma cells results in dysregulation of genes implicated in the canonical axon guidance pathway.

Authors:  Padmaja Kunapuli; Ken Lo; Lesleyann Hawthorn; John K Cowell
Journal:  Genomics       Date:  2009-10-14       Impact factor: 5.736

5.  Chromosome engineering in mice.

Authors:  R Ramírez-Solis; P Liu; A Bradley
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

6.  Mutagenic insertion and chromosome engineering resource (MICER).

Authors:  David J Adams; Patrick J Biggs; Tony Cox; Rob Davies; Louise van der Weyden; Jos Jonkers; James Smith; Bob Plumb; Ruth Taylor; Ichiko Nishijima; Yuejin Yu; Jane Rogers; Allan Bradley
Journal:  Nat Genet       Date:  2004-07-04       Impact factor: 38.330

Review 7.  The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders.

Authors:  Eike Staub; Jordi Pérez-Tur; Reiner Siebert; Carlo Nobile; Nicholas K Moschonas; Panagiotis Deloukas; Bernd Hinzmann
Journal:  Trends Biochem Sci       Date:  2002-09       Impact factor: 13.807

Review 8.  Genetics of the epilepsies.

Authors:  Eva Gutierrez-Delicado; José M Serratosa
Journal:  Curr Opin Neurol       Date:  2004-04       Impact factor: 5.710

9.  LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway.

Authors:  Padmaja Kunapuli; Chitta S Kasyapa; Lesleyann Hawthorn; John K Cowell
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

10.  Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families.

Authors:  Roberto Michelucci; Juan Jose Poza; Vito Sofia; Maria Rita de Feo; Simona Binelli; Francesca Bisulli; Evan Scudellaro; Barbara Simionati; Rosanna Zimbello; Giuseppe D'Orsi; Daniela Passarelli; Patrizia Avoni; Giuliano Avanzini; Paolo Tinuper; Roberto Biondi; Giorgio Valle; Victor F Mautner; Ulrich Stephani; Carlo Alberto Tassinari; Nicholas K Moschonas; Reiner Siebert; Adolpho Lopez de Munain; Jordi Perez-Tur; Carlo Nobile
Journal:  Epilepsia       Date:  2003-10       Impact factor: 5.864

View more
  46 in total

1.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

Authors:  Meizan Lai; Maartje G M Huijbers; Eric Lancaster; Francesc Graus; Luis Bataller; Rita Balice-Gordon; John K Cowell; Josep Dalmau
Journal:  Lancet Neurol       Date:  2010-06-28       Impact factor: 44.182

2.  The LGI1-ADAM22 protein complex directs synapse maturation through regulation of PSD-95 function.

Authors:  Kathryn L Lovero; Yuko Fukata; Adam J Granger; Masaki Fukata; Roger A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-15       Impact factor: 11.205

Review 3.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 4.  The very large G protein coupled receptor (Vlgr1) in hair cells.

Authors:  Jin-Peng Sun; Rong Li; Hong-Ze Ren; An-Ting Xu; Xiao Yu; Zhi-Gang Xu
Journal:  J Mol Neurosci       Date:  2012-11-20       Impact factor: 3.444

Review 5.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

6.  Putting the Horse Before the Cart: Looking to Presynaptic Mechanisms in Genetic Models.

Authors:  Matthew Weston
Journal:  Epilepsy Curr       Date:  2016 Jul-Aug       Impact factor: 7.500

7.  Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype.

Authors:  Yong Teng; Xiayang Xie; Steven Walker; Grzegorz Rempala; David J Kozlowski; Jeff S Mumm; John K Cowell
Journal:  Hum Mol Genet       Date:  2010-09-06       Impact factor: 6.150

8.  Etiology of a genetically complex seizure disorder in Celf4 mutant mice.

Authors:  J L Wagnon; C L Mahaffey; W Sun; Y Yang; H-T Chao; W N Frankel
Journal:  Genes Brain Behav       Date:  2011-08-03       Impact factor: 3.449

Review 9.  Encephalitis and antibodies to synaptic and neuronal cell surface proteins.

Authors:  Eric Lancaster; Eugenia Martinez-Hernandez; Josep Dalmau
Journal:  Neurology       Date:  2011-07-12       Impact factor: 9.910

10.  Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy.

Authors:  Norihiko Yokoi; Yuko Fukata; Daisuke Kase; Taisuke Miyazaki; Martine Jaegle; Toshika Ohkawa; Naoki Takahashi; Hiroko Iwanari; Yasuhiro Mochizuki; Takao Hamakubo; Keiji Imoto; Dies Meijer; Masahiko Watanabe; Masaki Fukata
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.